Embla Medical hf (OCSE:EMBLA)
kr 35.3 0.8 (2.32%) Market Cap: 15.07 Bil Enterprise Value: 18.38 Bil PE Ratio: 31.89 PB Ratio: 2.86 GF Score: 71/100

Q4 2021 Ossur hf Earnings Call Transcript

Feb 01, 2022 / 08:00AM GMT
Release Date Price: kr40.6 (+4.10%)
Operator

Ladies and gentlemen, welcome to the Ãssur Q4 and Financial Year 2021 Results. (Operator Instructions)

Today, I am pleased to present CEO and President, Jon Sigurdsson; and CFO, Sveinn Solvason. Speakers, please begin.

Jon Sigurdsson;ssur hf.;CEO;President
Ã

&

Yes. Thanks for that. And I would like to welcome you to the Ãssur investor conference call where we will cover the results for the fourth quarter and full year of 2021, as previously mentioned. My name is Jon Sigurdsson. I'm the President and CEO. And with me here today is Sveinn Solvason, our CFO.

We will begin by going through the highlights of the quarter, followed by the highlights of the year and ending with the guidance for 2022. A question-and-answer session will then follow.

The next slide, please. Sales for the fourth quarter of 2021 amounted to $188 million, which corresponds to 5% organic growth compared to $170 million in the same quarter last year and 4% decline organic in the quarter.

Prosthetics

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot